Skip to main content

Meeting the Healthcare Needs of Canadians

+1 (800) 737-3928

Trimedic Therapeutics

Identify and address opportunities to improve outcomes for patients within the health care system

Our Approach

Searching the world for products that will improve the quality of care and health outcomes for Canadians

Company Background

Headquartered in Toronto Canada, Trimedic Therapeutics Inc (TTI), was established in 2019 following the successful sale of Celopharma Inc., a pharmaceutical company founded by Marty Tenenbaum the principal partner of Celopharma, to a European international pharmaceutical industry leader in a multi million-dollar cash transaction.

The TTI Team are a small group of 12 experienced pharma executives with more than 200 years of collective expertise in the pharma industry. Our strong core values reflect hard work, honesty, integrity, transparency and a determination to improve health outcomes for Canadians.

TTI’s management team has a long history of creating significant value for all stakeholders and employees, at every opportunity.

Languages spoken include English, French, Spanish, Mandarin and Serbian.

people meeting
sales offices-canada

Sales Offices and Distribution Centres Across Canada

Head Office & Sales Distribution – Toronto, Canada

Sales Office and Pharma Distribution Centre Canada – Quebec, East Coast

Sales Office – British Columbia West to Manitoba

Key Team Members

marty tenenbaum

MARTY TENENBAUM

BA, BBA
Schulich School
of Business, York
University, Toronto
CEO

SIMON JAY

B.Comm., MBA
Chief Commercial Officer
Pricing & Market Access,
Strategic Marketing

simon jay
john boyack

JOHN BOYACK

BSc Computer Science
Chief Sales & Technology
Officer, Devices and
Diagnostics

DR. CHARLES PIWKO

PharmD., PhD., MSc
Health Policy
Senior Clinical Consultant

charles
aran kwinta

ARAN KWINTA

LLB
York University
Osgoode Hall Law School

SAMMI CHAN

BA, CPA
University of Toronto
CFO

sammi
tom

TOM OSTOJIC

Chief Regulatory Officer
Health Canada, FDA,
Provincial Regulatory
Processes

OLIVER KHAN

B.Comm.,
Queens University
Finance/Advisor

oliver-khan

Latest News

people in meeting

First novel beta-blocker in over 20 years

Novel beta-blocker Announcement Development and clinical data from the European Healthcare company…

Read More